Studies suggest that combining recommended CRC screening methodologies with detection of stool inflammatory markers, such as lactoferrin and sIgA, may increase the sensitivity and specificity of adenoma and CRC detection [11,26]. The gene discussed is LTF; the disease is colorectal carcinoma.